Article

(disponible) - Article
Preclinical diagnosis of Alzheimer's disease : prevention or prediction? / NITRINI, Ricardo.
Dementia & neuropsychologia, 2010, vol. 4 (4 (dec.)), p. 259-261.

http://www.demneuropsy.com.br/imageBank/PDF/v4n4a02.pdf... (30-01-2012)

Mots-clés principaux
:
Maladie d'Alzheimer
Diagnostic précoce
Prévention
Dépistage


Résumé :

The diagnosis of Alzheimer's disease (AD) for cases with dementia may be too late to allow effective treatment. Criteria for diagnosis of preclinical AD suggested by the Alzheimer's Association include the use of molecular and structural biomarkers. Preclinical diagnosis will enable testing of new drugs and forms of treatment toward achieving successful preventive treatment. But what are the advantages for the individual? To know that someone who is cognitively normal is probably going to develop AD's dementia when there is no effective preventive treatment is definitely not good news. A research method whereby volunteers are assigned to receive treatment or placebo without knowing whether they are in the control or at-risk arm of a trial would overcome this potential problem. If these new criteria are used wisely they may represent a relevant milestone in the search for a definitive treatment for AD.

Langue : Anglais
Doc n° : 28923
NumRec : 6070603
 

       

  Copier Permanent URL de cette page Ajouter cette page

     

disponible
Réserver
Pour réserver ce document, vous devez d'abord vous connecter


Aller vers :   IUGM    Fondation IUGM   Centre de recherche IUGM